Cayman Chemical TebIpenm PIvoxIl 10mg
A prodrug form of tebipenem; metabolized by CES in intestinal epithelial cells to form tebipenem; active against methicillin-sensitive and -resistant S. aureus (MIC90s = ≤0.125 and 16 UG/ml, respectively), as well as E. faecalis, E. coli., K. pneumoniae, E. aerogenes, H. influenzae, and P. aeruginosa (MIC90s = 32, 1, 0.5, ≤0.125, 0.25, and 64 UG/ml, respectively); increases survival in mouse models of sepsis induced by S. aureus, E. coli, or P. aeruginosa at 50 and 100 mg/kg